Abstract:
Objective To study the clinicopathologic characteristics, molecular phenotypes, and prognosis of breast mucinous carcinoma(MC).
Methods Data from 242 metastatic breast cancer(MBC) patients who underwent surgery between January 2004 and December 2010 were reviewed.Cases of invasive ductal carcinoma(IDC) of the breast during the corresponding period were randomly selected as matched controls.The clinicopathologic characteristics and prognosis were retrospectively analyzed.
Results Statistical analysis showed that pure MC differed from mixed MC with respect to lymph node status, ultrasound diagnosis, and expression of p53 and disease-free survival rate(DFS)(P < 0.05).No significant difference was observed in terms of age, menstrual status, family history, tumor size, and overall survival rate(OS)(P > 0.05).MBC was associated with better OS and DFS than IDC, and their molecular phenotypes were significantly different(P < 0.05).
Conclusion MBC has a better prognosis than IDC.Distinct clinicopathologic characteristics and prognoses exist for pure MC and mixed MC.Successful diagnosis of breast MC is critical for clinical treatment guidance and prognosis establishment.